Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial
抗CD38单克隆抗体CM313治疗系统性红斑狼疮:一项随机、双盲、安慰剂对照的Ib/IIa期试验
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02487-2
Zhao, Jiuliang; Lin, Changsong; Xie, Qibing; Shu, Qiang; Cui, Yang; Luo, Hui; Fan, Wenqiang; Huang, Anbin; Zhao, Yi; Fu, Zili; Xie, Changhao; Wu, Huaxiang; Yang, Niansheng; He, Lan; Feng, Ping; Zhang, Tiandong; Zhou, Huan; Liu, Wei; Hou, Qiaoyun; Mao, Xihua; Sun, Jing; Chen, Bo; Zeng, Xiaofeng